Copyright © AcuityBio Corporation 2018. All rights reserved.

Primary Contact: jschwartz@acuitybio.com 

Created by Brodly Inc. 

NEWS

November 5, 2019

Newton, Massachusetts, (Nov. 05, 2019) 

AcuityBio Corporation, a developer of novel drug-delivery combination products, announced that it has received a notice of allowance from the United States Patent and Trademark Office for Application 20170172720 . “

“We are extremely pleased to have received this patent allowance. This allowance further validates the...

August 6, 2018

Press Release Acuity Bio CEO interviewed by StockTube Dr. John Jay Schwartz interviewed in regards to Acuity Bio’s proprietary ABC103 Product.

Newton, Massachusetts (August 4, 2018) – Acuity Bio Inc., a developer of novel drug delivery, combination products, announced today that its CEO John Jay Schwartz has been interviewed by Stocktube in regards to Acui...

Please reload